Table 5.
Correlation analysis between “fibrinogen”/“albumin”/“Fib-Alb score” and clinicopathological characteristics in GC cancer.
| Fibrinogen | P | Albumin | P | Fib-Alb score | P | ||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | |||||||
| Vascular invasion | Negative | 3.31 ± 1.12 | 0.795 | 37.44 ± 5.55 | 0.181 | 117 (31.1) | 77 (23.5) | 31 (22.3) | 0.034 |
| Positive | 3.29 ± 0.89 | 36.89 ± 5.08 | 259 (68.9) | 260 (76.5) | 108 (77.7) | ||||
|
| |||||||||
| Pathological type | Tubular adenocarcinoma | 3.30 ± 0.93 | 0.505 | 36.95 ± 5.31 | 0.173 | 316 (84.0) | 278 (85.0) | 125 (89.9) | 0.139 |
| Signet-ring cell carcinoma | 3.18 ± 0.97 | 38.10 ± 3.61 | 42 (11.2) | 26 (8.0) | 7 (5.0) | ||||
| Other types | 3.38 ± 1.28 | 36.73 ± 5.69 | 18 (4.8) | 23 (7.0) | 7 (5.0) | ||||
|
| |||||||||
| Histological grading | Poorly differentiated | 3.26 ± 0.92 | 0.177 | 37.03 ± 5.26 | 0.967 | 274 (72.9) | 217 (66.4) | 95 (68.3) | 0.163 |
| Well or moderately differentiated | 3.36 ± 1.04 | 37.05 ± 3.12 | 102 (27.1) | 110 (36.6) | 44 (31.7) | ||||